These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 22220825

  • 1. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.
    Bangalore S, Ley L.
    Expert Opin Pharmacother; 2012 Feb; 13(3):345-55. PubMed ID: 22220825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Issues in blood pressure control and the potential role of single-pill combination therapies.
    Burnier M, Brown RE, Ong SH, Keskinaslan A, Khan ZM.
    Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
    [Abstract] [Full Text] [Related]

  • 7. Long-term blood pressure control: what can we do?
    Neutel JM.
    Postgrad Med; 2011 Jan; 123(1):88-93. PubMed ID: 21293088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Jan; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
    Guthrie RM.
    Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
    [Abstract] [Full Text] [Related]

  • 18. Optimizing blood pressure control through the use of fixed combinations.
    Düsing R.
    Vasc Health Risk Manag; 2010 May 25; 6():321-5. PubMed ID: 20531950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.